-
公开(公告)号:US20090124654A1
公开(公告)日:2009-05-14
申请号:US11884595
申请日:2006-02-23
IPC分类号: A61K31/4725 , C07D409/12 , A61P9/10
CPC分类号: A61K31/47 , C07D217/26
摘要: This invention provides aryl and heteroaryl compounds of formula (X). The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. Formula (X) wherein R102 is selected from the group consisting of —C(O)OH, —C(O)OCH3, —C(O)O-t-butyl, —C(O)NH—OCH2-phenyl, C(O)NHOH, and —C(O)NHSO2CH3; and wherein R101, R103, R104 and Y are as defined herein.
摘要翻译: 本发明提供式(X)的芳基和杂芳基化合物。 本发明的化合物可用作拮抗剂或因子IX和/或因子XI的部分拮抗剂,因此可用于抑制凝血的内在途径。 式(X)其中R 102选自-C(O)OH,-C(O)OCH 3,-C(O)叔丁基,-C(O)NH-OCH 2 - 苯基,C(O )NHOH和-C(O)NHSO 2 CH 3; 并且其中R 101,R 103,R 104和Y如本文所定义。
-
公开(公告)号:US07544699B2
公开(公告)日:2009-06-09
申请号:US10913168
申请日:2004-08-06
申请人: Adnan M. M. Mjalli , Robert C. Andrews , Xiao-Chuan Guo , Daniel Peter Christen , Devi Reddy Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
发明人: Adnan M. M. Mjalli , Robert C. Andrews , Xiao-Chuan Guo , Daniel Peter Christen , Devi Reddy Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
IPC分类号: C07D217/00 , A61K31/47
CPC分类号: C07D295/155 , C07C233/87 , C07C235/42 , C07C235/52 , C07C235/60 , C07C235/66 , C07C237/36 , C07C237/42 , C07C271/20 , C07C311/08 , C07C311/09 , C07C311/21 , C07C311/44 , C07C317/32 , C07C323/36 , C07C2601/08
摘要: This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be useful for inhibiting the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway.
摘要翻译: 本发明提供芳基和杂芳基化合物,其制备方法,包含该化合物的药物组合物及其在治疗人或动物病症中的用途。 本发明的化合物可以是拮抗剂或因子IX和/或因子XI的部分拮抗剂,因此可用于抑制凝血的内在途径。 所述化合物可用于各种应用,包括部分由内在凝血途径引起的疾病的管理,治疗和/或控制。
-
公开(公告)号:US07208601B2
公开(公告)日:2007-04-24
申请号:US11069521
申请日:2005-03-01
IPC分类号: C07D217/00
CPC分类号: A61K31/47 , C07D217/26 , C07D405/04 , C07D405/12 , C07D409/12
摘要: This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX and/or XI.
摘要翻译: 本发明提供芳基和杂芳基化合物,其制备方法,包含该化合物的药物组合物及其在治疗人或动物病症中的用途。 本发明的化合物可用作拮抗剂或因子IX和/或因子XI的部分拮抗剂,因此可用于抑制凝血的内在途径。 所述化合物可用于各种应用,包括通过利用因子IX和/或XI的部分凝血途径引起的疾病的管理,治疗和/或控制。
-
4.
公开(公告)号:US07122580B2
公开(公告)日:2006-10-17
申请号:US10637900
申请日:2003-08-08
申请人: Adnan M. M. Mjalli , Robert C. Andrews , Xiao-Chuan Guo , Daniel Peter Christen , Devi Reddy Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
发明人: Adnan M. M. Mjalli , Robert C. Andrews , Xiao-Chuan Guo , Daniel Peter Christen , Devi Reddy Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
IPC分类号: A61K31/245 , C07C233/87
CPC分类号: C07D207/267 , C07C233/29 , C07C233/87 , C07C235/42 , C07C235/52 , C07C235/60 , C07C235/66 , C07C237/36 , C07C237/42 , C07C237/44 , C07C255/60 , C07C257/18 , C07C271/20 , C07C271/44 , C07C311/18 , C07C311/19 , C07C311/44 , C07C317/14 , C07C317/28 , C07C317/36 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2603/74 , C07D207/09 , C07D211/26 , C07D213/30 , C07D213/70 , C07D213/71 , C07D213/74 , C07D213/81 , C07D217/02 , C07D217/16 , C07D217/22 , C07D231/12 , C07D231/14 , C07D231/18 , C07D233/84 , C07D239/94 , C07D249/08 , C07D261/10 , C07D263/32 , C07D271/10 , C07D277/46 , C07D285/08 , C07D295/088 , C07D295/155 , C07D307/66 , C07D307/79 , C07D307/85 , C07D317/60 , C07D333/24 , C07D333/38 , C07D333/70 , C07D401/04 , C07D409/04 , C07D409/06 , C07D413/04
摘要: This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.
摘要翻译: 本发明提供某些化合物,其制备方法,包含该化合物的药物组合物及其在治疗人或动物疾病中的用途。 本发明的化合物可用作拮抗剂,或更优选为因子IX的部分拮抗剂,因此可用于抑制血液凝固的内在途径。 该化合物可用于各种应用,包括通过利用因子IX的内在凝血途径部分引起的疾病的管理,治疗和/或控制。 这些疾病或疾病状态包括中风,心肌梗死,动脉瘤手术以及与外科手术相关的深部静脉血栓形成,长时间的约束,以及获得性或遗传的促凝血状态。
-
公开(公告)号:US20070254916A1
公开(公告)日:2007-11-01
申请号:US11714031
申请日:2007-03-05
申请人: Adnan Mjalli , Devi Gohimmukkula , Sameer Tyagi
发明人: Adnan Mjalli , Devi Gohimmukkula , Sameer Tyagi
CPC分类号: A61K31/47 , C07D217/26 , C07D405/04 , C07D405/12 , C07D409/12
摘要: This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX and/or XI.
-
公开(公告)号:US20050059705A1
公开(公告)日:2005-03-17
申请号:US10913168
申请日:2004-08-06
申请人: Adnan Mjalli , Robert Andrews , Xiao-Chuan Guo , Daniel Christen , Devi Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
发明人: Adnan Mjalli , Robert Andrews , Xiao-Chuan Guo , Daniel Christen , Devi Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
IPC分类号: A61P31/12 , C07C233/87 , C07C235/42 , C07C235/52 , C07C235/60 , C07C235/66 , C07C237/36 , C07C237/42 , C07C271/20 , C07C311/08 , C07C311/09 , C07C311/21 , C07C311/44 , C07C317/32 , C07C323/36 , C07D295/155 , C07D41/02 , A61K31/4439 , C07D43/02
CPC分类号: C07D295/155 , C07C233/87 , C07C235/42 , C07C235/52 , C07C235/60 , C07C235/66 , C07C237/36 , C07C237/42 , C07C271/20 , C07C311/08 , C07C311/09 , C07C311/21 , C07C311/44 , C07C317/32 , C07C323/36 , C07C2601/08
摘要: This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be useful for inhibiting the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway.
摘要翻译: 本发明提供芳基和杂芳基化合物,其制备方法,包含该化合物的药物组合物及其在治疗人或动物病症中的用途。 本发明的化合物可以是拮抗剂或因子IX和/或因子XI的部分拮抗剂,因此可用于抑制凝血的内在途径。 所述化合物可用于各种应用,包括部分由内在凝血途径引起的疾病的管理,治疗和/或控制。
-
公开(公告)号:US20060276518A1
公开(公告)日:2006-12-07
申请号:US11500225
申请日:2006-08-07
申请人: Adnan Mjalli , Robert Andrews , Xiao-Chuan Guo , Daniel Christen , Devi Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
发明人: Adnan Mjalli , Robert Andrews , Xiao-Chuan Guo , Daniel Christen , Devi Gohimmukkula , Guoxiang Huang , Robert Rothlein , Sameer Tyagi , Tripura Yaramasu , Christopher Behme
IPC分类号: A61K31/44 , A61K31/40 , A61K31/18 , A61K31/16 , A61K31/175
CPC分类号: C07D207/267 , C07C233/29 , C07C233/87 , C07C235/42 , C07C235/52 , C07C235/60 , C07C235/66 , C07C237/36 , C07C237/42 , C07C237/44 , C07C255/60 , C07C257/18 , C07C271/20 , C07C271/44 , C07C311/18 , C07C311/19 , C07C311/44 , C07C317/14 , C07C317/28 , C07C317/36 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2603/74 , C07D207/09 , C07D211/26 , C07D213/30 , C07D213/70 , C07D213/71 , C07D213/74 , C07D213/81 , C07D217/02 , C07D217/16 , C07D217/22 , C07D231/12 , C07D231/14 , C07D231/18 , C07D233/84 , C07D239/94 , C07D249/08 , C07D261/10 , C07D263/32 , C07D271/10 , C07D277/46 , C07D285/08 , C07D295/088 , C07D295/155 , C07D307/66 , C07D307/79 , C07D307/85 , C07D317/60 , C07D333/24 , C07D333/38 , C07D333/70 , C07D401/04 , C07D409/04 , C07D409/06 , C07D413/04
摘要: This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as antagonists, or more preferably, partial antagonist of factor IX and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds are useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX. Such diseases or disease states include stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures, long periods of confinement, and acquired or inherited pro-coagulant states.
-
公开(公告)号:US20050171148A1
公开(公告)日:2005-08-04
申请号:US11069521
申请日:2005-03-01
申请人: Adnan Mjalli , Devi Gohimmukkula , Sameer Tyagi
发明人: Adnan Mjalli , Devi Gohimmukkula , Sameer Tyagi
IPC分类号: C07C233/87 , C07C235/42 , C07C235/52 , C07C235/60 , C07C235/66 , C07C237/36 , C07C237/42 , C07C271/20 , C07C311/08 , C07C311/09 , C07C311/21 , C07C311/44 , C07C317/32 , C07C323/36 , C07D295/155 , A61K31/4709 , C07D45/02 , C07D49/02
CPC分类号: A61K31/47 , C07D217/26 , C07D405/04 , C07D405/12 , C07D409/12
摘要: This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX and/or XI.
摘要翻译: 本发明提供芳基和杂芳基化合物,其制备方法,包含该化合物的药物组合物及其在治疗人或动物病症中的用途。 本发明的化合物可用作拮抗剂或因子IX和/或因子XI的部分拮抗剂,因此可用于抑制凝血的内在途径。 所述化合物可用于各种应用,包括通过利用因子IX和/或XI的部分凝血途径引起的疾病的管理,治疗和/或控制。
-
-
-
-
-
-
-